Randomised controlled trial on the effect of simethicone bowel preparation on rectal variability during image ‐guided radiation therapy for prostate cancer (SPoRT study)

ConclusionsSimethicone did not decrease the RV or GV overall. However, simethicone appeared to significantly decrease the RV variability from Week three onwards. This suggests that taking simethicone two to three weeks before starting radiation therapy may reduce RV variability, although a larger study is needed to confirm this.

Source: Journal of Medical Imaging and Radiation Oncology - March 25, 2022 Category: Radiology Authors: Jennifer Ward, Suki Gill, Kevin Armstrong, Tamara Fogarty, Daren Tan, Alison Scott, Aylin Yahya, Satvinder Singh Dhaliwal, Angela Jacques, Colin Tang Tags: Radiation Oncology —Original Article Source Type: research